The Business Research Company’s report on the Automated Nucleic Acid Extraction Devices Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
What are the key drivers behind the automated nucleic acid extraction devices market’s growth in recent years?
A growing number of research and development activities is expected to propel the growth of the automated nucleic acid extraction devices market going forward. Research and development activities are activities carried out by businesses to inquire about and gather market information prior to the start of the development process in order to create and introduce new goods and services to the market and increase the bottom line of the business. The automated nucleic acid extraction devices are used in research and development activities for clinical diagnosis, biological analysis, and environmental monitoring to boost companies’ efforts to develop new solutions. For instance, in July 2022, according to the World Health Organization (WHO), a Switzerland-based specialized health agency of the United Nations, due to the increasing investment made by the countries during the COVID-19 pandemic, the percentage of nations equipped to conduct genomic surveillance rose from 54% to 68% between March 2021 and January 2022. Therefore, the growing number of research and development activities is driving the growth of the automated nucleic acid extraction devices market.
Access Your Free Sample of the Global Automated Nucleic Acid Extraction Devices Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=9421&type=smp
How does the future projection of the automated nucleic acid extraction devices market size compare to its historical growth?
The automated nucleic acid extraction devices market size has grown rapidly in recent years. It will grow from $5.93 billion in 2024 to $6.63 billion in 2025 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to increasing demand for molecular diagnostics, growing awareness of the benefits of automation, expansion of the pharmaceutical and biotechnology industries, government initiatives to promote molecular diagnostics, growing demand for molecular diagnostics.
The automated nucleic acid extraction devices market size is expected to see rapid growth in the next few years. It will grow to $11.31 billion in 2029 at a compound annual growth rate (CAGR) of 14.3%. The growth in the forecast period can be attributed to increased demand for personalized medicine, increasing demand for automation, increasing focus on precision medicine, increasing demand for point-of-care testing, integration with next-generation sequencing. Major trends in the forecast period include technological advancements, increasing demand for molecular diagnostics, miniaturization of automated systems, point-of-care testing, integration of artificial intelligence (AI) and data analytics.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=9421&type=smp
Which key players are shaping the future of the automated nucleic acid extraction devices market?
Major companies operating in the automated nucleic acid extraction devices market include QIAGEN NV, PerkinElmer Inc., F. Hoffmann-La Roche AG, Die Analytik Jena GmbH, Thermo Fisher Scientific Inc., Accubiomed Co. Ltd., AutoGen Inc., Bioneer Corporation, Illumina Inc., Tecan Trading AG, Merck Co. & KGaA, Becton Dickinson and Company, DiaSorin Molecular LLC, BioTeke Corporation (Wuxi) Co. Ltd., Tianlong-Xi’an TianLong Science and Technology Co. Ltd., Jiangsu Bioperfectus Technologies Co. Ltd., Hangzhou Bloer Technology Co. Ltd., MGI Tech Co. Ltd., Aurora Biomed Inc., Promega Corporation, Hamilton Company, Tecan Group Ltd., Beckman CoulterInc., Bio-Rad Laboratories Inc., Zymo Research Corporation, Agilent Technologies Inc., Danaher Corporation, BioChain Institute Inc., Biomatrica Inc., Corbett Life Science Pty Ltd., Eppendorf AG, GE Healthcare Life Sciences, GenScript Biotech Corporation, Greiner Bio-One International GmbH, IntegenX Inc., LGC Biosearch Technologies, MicroGEM International Company, Norgen Biotek Corp.
What trends will propel the growth and evolution of the automated nucleic acid extraction devices market?
Product innovation is a key trend gaining popularity in the market for automated nucleic acid extraction devices. Major companies operating in the automated nucleic acid extraction devices market are introducing innovative products to sustain their position in the market. For instance, in August 2022, Aurora Biomed, a Canada-based manufacturer of automated medical equipment, introduced the VERSA NAP Automated DNA Extraction Systems (also known as the automated nucleic acid extraction system) to automate DNA and RNA extractions and their related purification protocols. The system can process 1-96 samples at the same time and is capable of isolating pure, high-quality DNA or RNA with its plate grippers and transporters and gives high nucleic acid results.
Which regions are expected to become dominant players in the automated nucleic acid extraction devices market?
North America was the largest region in the automated nucleic acid extraction devices market in 2024. The regions covered in the automated nucleic acid extraction devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Order Your Report Now For Swift Delivery
What are the emerging key segments in the automated nucleic acid extraction devices market, and how are they evolving?
The automated nucleic acid extraction devices market covered in this report is segmented –
1) By Type: Instruments, Kits, Consumables
2) By Product: Fully Automated, Semi-Automated
3) By End User: Hospitals, Diagnostic Centers, Forensic Laboratories, Pharmaceutical And Biotechnology Companies, Academic Research Institutes
Subsegments:
1) By Instruments: Automated Extractors, Liquid Handling Systems
2) By Kits: DNA Extraction Kits, RNA Extraction Kits, Viral Nucleic Acid Extraction Kits
3) By Consumables: Reagents, Columns, Tips And Tubes
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9421
How is the automated nucleic acid extraction devices market defined?
Automated nucleic acid extraction devices refer to the equipment used for the major amplification processes such as isolation, purification, and concentration to detect specific pathogens in the molecular diagnostic method. These are used to save time and labor when compared to manual extraction of nucleic acids from the same number of samples.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
